AI for Digital Pathology

Instead of starting with a broad, high-risk goal such as full cancer grading or complex biomarker scoring, it is usually safer to begin with a narrower workflow, such as scan QC, tissue or region-of-interest (ROI) detection, or second-read triage. These use cases are easier to validate, fit more naturally into real workflows, and help product teams build evidence and user confidence. It is also important to define the intended use and regulatory posture early, for example, whether the AI is meant for research support, review support, or a more advanced diagnostic use case, because that decision shapes the data strategy, validation burden, workflow design, and product claims.

Many digital pathology products already have a viewer, storage layer, and core case workflow in place, but lack the controls needed to introduce AI features cleanly, such as triage queues, labeling workflows, role-specific review views, and admin controls for thresholds and exceptions. A practical approach is to add AI as a modular layer rather than rebuild the entire product. This layer can include separate inference services, model management, overlays or heatmaps, and review workflows such as triage, review, and disagreement resolution. This helps product companies release AI features faster and iterate on them without destabilizing the core platform.

AI adoption stalls when pathologists do not trust outputs or cannot explain them. Design your AI pathology software so the human decision is the product’s center: show heatmaps and regions together with confidence scores or confidence levels, provide “why flagged” context, and support easy overrides (confirm, reject, defer). Every AI output should be traceable: model version, data version, thresholds used, and the final human action. This turns your AI from a black box into a reviewable decision-support tool, and it is also the foundation for audits, clinical validation packages, and future regulated pathways.

“It worked in the lab” often fails in production because stain protocols, tissue prep, scanners, compression, and focus artifacts vary across sites. Best practice is to treat variability as a first-class requirement: validate on multi-site data, track performance by scanner, stain, or subtype, and deploy drift monitoring (e.g., slide quality signals, embedding distribution shifts, and error rates by cohort). When confidence drops or drift is detected, route cases to a “human-first” path and trigger an active-learning loop to capture hard cases, label them, and retrain with controlled releases instead of silent model degradation.

AI evaluation should be structured so that every model release is tested the same way and the results can be compared over time. A practical approach is to build a versioned, automated evaluation pipeline with fixed dataset splits, ground-truth provenance, cohort-level metrics, and regression checks for every release. Track not only overall performance metrics, but also failure patterns such as false positives by tissue type, sensitivity by tumor subtype, and performance under slide quality issues. These findings should guide model evolution: they help product teams identify weak spots, refine thresholds, prioritize new data collection and labeling, and target retraining where it matters most.

Whole-slide images are very large, so costs rise quickly when systems process full slides unnecessarily, store too much derived data, or keep all image data in high-performance storage. A more efficient approach is to split slides into smaller image patches only when needed for analysis, cache frequently viewed zoom levels or image areas so they do not have to be regenerated or reloaded every time, define how long raw slides and derived data should be retained, and separate frequently accessed data from lower-cost archival storage. For AI inference, product teams should group image patches into efficient processing batches, scale GPU resources up or down based on workload, and track cost per processed slide as an operating metric. If customers need cloud, on-prem, or hybrid deployment, the inference service should be built to run across environments without major rework, for example by packaging it in containers and designing it to work with GPU-enabled infrastructure. This helps product teams control storage and compute costs without turning each deployment into a custom engineering project.